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June Supplement 201174S Abstractslence of TASC II D infrapopliteal disease (P0.02).
Primary patency rates among the three ethnic groups
remained similar at 1 year, however the Latino group
displayed poorer patency after one year compared to
Blacks and Caucasians (P0.02). All three ethnic groups
had a similar one year amputation rate of 6.4%.
Conclusions: There does not appear to be a signifi-
cant difference among racial groups in clinical presenta-
tion. There are disparate lesion distributions among the
three ethnic groups, with more severe TASC II D infr-
apopliteal disease in the Latino group, possibly affecting
primary patency rates. There was no clear ethnic differ-
ence amongst the groups with regards to overall ampu-
tation rate.
Author Disclosures: Y. Etkin: Nothing to disclose; N. J.
Gargiulo: Nothing to disclose; E. C. Lipsitz: Nothing to
disclose; D. J. O’Connor: Nothing to disclose; A. Raju:
Nothing to disclose; O. Riaz: Nothing to disclose; L. A.
Scher: Nothing to disclose; W. D. Suggs: Nothing to
disclose.
C3h: Poster Session - Dialysis Access; Educational/
Training Credentialing; Other.
PS170.
Inadvertent Great Vessel Arterial Catheterization Dur-
ing Ultrasound-Guided Central Venous Line Place-
ment: A Potentially Fatal Event
Lakshmikumar Pillai, Pamela M. Zimmerman, Alexandre
C. d’ Audiffret. Surgery, West Virginia University Medical
Center, Morgantown, WV
Objectives: To review the incidence, efficacy of treat-
ment, and outcome of inadvertent subclavian and carotid
artery catheterization (arterial catheter placement, not sim-
ple cannulation by entry needle) during central venous
access procedures which required open vascular and/or
endovascular repair.
Methods: 5-year retrospective review of all central
venous access procedures performed at a teaching hospital.
Results: From 2005-10 a total of 10,731 central ve-
nous access procedures (“line placements”) were per-
formed. There were 132 (1%) pneumo and or hemo/
pneumothoarcies related to line placement. In 8 patients
there was inadvertent/unrecognized subclavian or carotid
artery catheterization requiring open and/or endovascular
repair. All 8 procedures were done under “ultrasound
guidance” by either Anesthesia or Critical Care Physicians
attempting jugular line placement in the OR or ICU.
Eighty-eight percent(7/8)vessels were successfully re-
paired.5/7 vessels(71%)were repaired using endovascular
methods and 2/7 vessels(29%)using open surgery. The
remaining injured vessel did not require repair due to
successful treatment of hemothorax with chest tube result-
ing in hemostasis at site of vessel injury. However,38%
(3/8) patients still subsequently expired including the lone
patient whose vessel did not require repair- the other two teaths occured in the patients who had undergone open
epair. All deaths were related to the intial injury. The right
ubclavian or carotid artery was the “fatal” vessel catheter-
zed in the deceased patients.
Conclusions: Though rare, inadvertent great vessel
atheterization during central line placement appears to
e a highly morbid and fatal event in 38% of the patients
n this study. Endovascular repair of these injuries ap-
ears to be better tolerated. Although ultrasound guid-
nce is the preferred method of jugular venous imaging
uring central vein catheterization, in this review it did
ot prevent inadvertent arterial catheterization and may
ndeed have imparted a false sense of security.
uthor Disclosures: A. C. d’ Audiffret: Nothing to
isclose; L. Pillai: Nothing to disclose; P. M. Zimmer-
an: Nothing to disclose
S172.
ngiotensin Receptor Blockers, Beta Blockers, and An-
iplatelet Agents Improve Primary Patency after Arte-
io-Venous Hemodialysis Access Placement
ubie S. Maybury1, Anton N. Sidawy2, Richard Amdur1,
obyn A. Macsata1. 1Veterans Affairs Medical Center,
ashington, DC; 2George Washington University Hospi-
al, Washington, DC
Objectives: Arterio-venous hemodialysis access
HDA) failure is a major cause of morbidity in end stage
enal disease. We examined the influence of medications on
DA primary patency (PP).
Methods: After IRB approval, we retrospectively ana-
yzed upper extremity HDA, excluding revisions, placed
rom 2005-2009 at the Washington, DC VAMedical Cen-
er. We used Cox proportional hazard models, adjusted for
atient and access characteristics, to assess the influence of
1 medication classes on PP.
Results: From 261 autogenous and 123 prosthetic
DA, we excluded 6 for unknown thrombosis date and
5 autogenous accesses for primary nonfunctionality.
e analyzed 213 autogenous and 120 prosthetic HDA.
wo yr PP rates were 49% for autogenous vs. 30% for
rosthetic HDA. On multivariable analysis, angiotensin
eceptor blockers (ARBs) and beta-blockers (BBs) re-
uced the risk of autogenous HDA failure, and ARBs
owered the risk of prosthetic HDA failure (Table). On
ubgroup analysis, ARBs prolonged autogenous HDA
atency only among patients using antiplatelet agents
HR 0.21, 95% CI 0.05 - 0.89, p 0.034), indicating that
oth drugs must be used in combination for either to be
ffective. For prosthetic HDA, there were no significant
rug-drug interactions. Model diagnostics showed low
ulticollinearity.
Conclusions:After HDA placement, administration of
RB plus an antiplatelet agent or BB (for autogenous
DA) or ARB (for prosthetic HDA) should be consideredo improve patency.
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Autogenous Access
(n  213)
Frosthetic Access
(n  120)
HR (95% CI) p-value HR (95% CI) p-value
Demographics
Increasing age
(years) 1.01 (0.98–1.03) 0.634 1.00 (0.97–1.03) 0.853
African American
Pace 0.56 (0.29–1.09) 0.090 1.48 (0.60–3.67) 0.398
Smoking status
Current Ref Ref
Former 1.00 (0.55–1.83) 0.999 1.38 (0.61–3.04) 0.455
Never 1.02 (0.49–2.14) 0.949 1.18 (0.50–2.79) 0.714
Comorbidities
Diabetes 1.21 (0.74–1.98) 0.444 2.12 (1.01–4.44) 0.047
Hypertension 0.88 (0.55–1.40) 0.584 1.45 (0.69–3.05) 0.326
Previous access in same
arm 0.78 (0.48–1.25) 0.309 0.83 (0.43–1.63) 0.594
Angiotensin receptor
blocker 0.35 (0.15–0.79) 0.012 0.40 (0.17–0.94) 0.035
Beta blocker 0.49 (0.27–0.90) 0.021 1.27 (0.68–2.36) 0.457
Antiplatelet medication 0.75 (0.41–1.37) 0.348 1.02 (0.56–1.86) 0.953
ACE inhibitor 0.80 (0.50–1.27) 0.340 0.51 (0.24–1.06) 0.072
Anti-angina agent 1.05 (0.57–1.95) 0.878 0.65 (0.18–2.30) 0.503
Anticoagulant 0.49 (0.16–1.49) 0.209 N/A1
Calcium channel
blocker 0.77 (0.46–1.31) 0.338 0.63 (0.33–1.23) 0.178
Diuretic 0.74 (0.45–1.23) 0.247 1.48 (0.62–3.43) 0.380
”Statin” (HMG Co-A
reductase
inhibitor) 1.32 (0.77–2.25) 0.312 0.59 (0.27–1.25) 0.166
Anti-hypertensive,
other 1.00 (0.57–1.75) 0.998 1.09 (0.40–2.95) 0.871
Lipid-lowering agent,
other 1.88 (0.58–6.09) 0.294 N/A1
Adjusted Relative Hazard of Access Failure
1Excluded from model due to small sample size using medication (antico-
agulant, n 3; lipid-lowering agent, other, n  1)
Author Disclosures: R. Amdur: Nothing to disclose;
R. A. Macsata: Nothing to disclose; R. S. Maybury:
Nothing to disclose; A. N. Sidawy: Nothing to disclose.
PS174.
Migration, Fracture, and Rupture as Complications of
Endovascular Grafts in the Treatment of Arteriovenous
Fistula
Dennis Wright1, Jill Zink1, Mirnal Chaudry2, Robert Net-
zley1, Victor Erzurum1. 1Akron General Medical Center,
Akron, OH; 2Northeastern Ohio Universities College of
Medicine, Rootstown, OH
Objectives:Endovascular stent grafts are utilized in the
rescue of failing AV access. Reports claim the superiorty of
stent grafts and recommended these as a first line treat-
ment. We have observed a rise in the number of complica-
tions related to stent grafts in our patients.
Methods: We reviewed all patients who had endovas-
cular stent grafts placed for treatment of failing dialysis
access over the last 36 months. A series of 27 consecutively
placed stent grafts was reviewed for stent migration, frac-
ture, hemorrhage and rupture at the site of the stent grafts.
Hospital charts were reviewed to assess for indications,
hemodynamic stability, transfusion requirement, and
outcome.
Results: Of 27 stent grafts placed, 9 were for pseudo-
aneurysm (PS), 15 for stenosis (ST), and 3 for a combina- pion (PS/ST). Six patients (22%) presented with complica-
ions (Table 1) related to migration, fracture, or rupture.
our of the six patients were in the pseudoaneurysm treat-
ent group. In all cases migration or fracture of the stent
raft lead to pseudoaneurysm formation. Four patient’s
equired ligation of the fistula to treat the complication and
wo dialysis access sites were salvaged.
Conclusions: Stent grafing of AV fistulas is seen in
ncreasing numbers of patients. Significant life threatening
omplication can arise when fracture and migration of the
tent grafts occur. Herald bleed with a previously placed
tent graft may be a harbinger of future rupture. Rupture
ppears less likely when stent grafts are used to treat steno-
is; surgical revision in the case of pseudoaneurysm should
e considered for access preservation.
able I.
Presentation and outcomes of stent graft complications # of pts
resented with significant bleeding episode 5
equired emergent/urgent operation 5
erald Bleed (At least 72 hrs prior to presentation) 4
ignificant hemodynamic instability (SBP 90) 3
equired blood transfusion ( 1 unit PRBC) 2
ardiopulmonary Arrest 1
ortality 0
uthor Disclosures: M. Chaudry: Nothing to disclose;
. Erzurum: Nothing to disclose; R. Netzley: Nothing to
isclose;D. Wright: Nothing to disclose; J. Zink: Nothing
o disclose.
S176.
hirty Day Outcomes following Brachiocephalic and
rachiobasilic Arteriovenous Fistula Formation: Na-
ional Benchmarks for Standard of Care
rateek K. Gupta1, Bala Natarajan1, Yeruva M. Reddy1,
imani Gupta1, Marcus Balters1, Jason M. Johanning2,
homas G. Lynch2, R. Armour Forse1, G. Matthew
ongo2, Jason N. MacTaggart2, Iraklis I. Pipinos2.
Creighton University, Omaha, NE; 2University of Ne-
raska Medical Center, Omaha, NE
Objectives: Dialysis access is one of the most fre-
uently performed vascular procedures, however, there is a
aucity of risk-adjusted, population-based data for postop-
rative outcomes following these procedures resulting in a
ack of national benchmarks for quality of care. The objec-
ive of this study was to report 30-day outcomes following
rachiocephalic and brachiobasilic arteriovenous fistula
AVF) formation.
Methods: Patients were identified from the American
ollege of Surgeons’ 2007-08 National Surgical Quality
mprovement Program (NSQIP) - a multicenter (more
han 180 hospitals), prospective database.
Results: In 2,037 patients, median age was 63 years
ith 53.7% being males and 52.1% Caucasians. Median
ody mass index was 28.3 kg/m2. Eighty nine percent
atients had hypertension, 47.0%were diabetics, and 78.7%
